The Oncology Nurse
  • Home
  • Issues
    • 2018
      • November 2018 - Vol 11 No 5
      • September 2018 - Vol 11 No 4
      • July 2018 - Vol 11 No 3
      • May 2018 - Vol 11 No 2
      • March 2018 - Vol 11 No 1
    • 2017
      • November 2017 - Vol 10 No 6
      • September 2017 - Vol 10 No 5
      • July 2017 - Vol 10 No 4
      • May 2017 - Vol 10 No 3
      • March Vol 10 No 2
      • January Vol 10 No 1
    • 2016
      • November Vol 9 No 6
      • September Vol 9 No 5
      • July Vol 9 No 4
      • May Vol 9 No 3
      • March Vol 9 No 2
      • January Vol 9 No 1
    • Issue Archive
    • Special Issues
      • 2018 Guide to New FDA Approvals
  • Supplements
  • Categories
  • Conference Correspondent
    • ESMO 2018
      • ESMO 2018 Wrap-Up
    • HNF 2018
    • ASH 2017 - ITP
    • SABCS 2017 - Breast Cancer
    • ONS 2017 - Immunotherapy
    • ASH 2016 - Roundup
    • ASH 2016 - Multiple Myeloma
    • ASH 2015 - Multiple Myeloma
  • Web Exclusives
    • Drug Updates
    • FDA Approvals, News & Updates
    • In the News
    • Online First
    • Press Releases
    • Media Library
      • Video Library
        • TON Interview with the Innovators Series
      • Audiocast Library
  • Quick Quiz
  • CE
  • About
    • Contact Us
    • Editorial Board
    • Advertise
    • Resources
    • For Authors
      • Author Guidelines
The Oncology Nurse

Harris S. Goodman, MD

Medical Director, Clinical Laboratory
Saint Francis Memorial Hospital
San Francisco, CA

Authored Items
Ensuring Consistent and Reliable Biomarker Testing
Harris S. Goodman, MD
Faculty Perspectives–Rationale for PD-L1 Expression as a Biomarker in Immuno-Oncology | Part 2 of a 4-Part Series
Ensuring Consistent and Reliable Biomarker Testing
Harris S. Goodman, MD
Faculty Perspectives: Rationale for PD-L1 Expression as a Biomarker in Immuno-Oncology | Part 2 of a 4-Part Series
Biomarkers and the Cancer Care Team: Critical Partners in Personalized Medicine
Harris S. Goodman, MD
Faculty Perspectives: An Overview of Existing and Emerging Biomarkers in Oncology | Part 1 of a 4-Part Series
Biomarkers and the Cancer Care Team: Critical Partners in Personalized Medicine
Harris S. Goodman, MD
Faculty Perspectives - An Overview of Existing and Emerging Biomarkers in Oncology | Part 1 of a 4-Part Series
Last modified: June 19, 2018
Sign Up Now!
To sign up for our newsletter or print publications, enter your contact information below.
First Name
Last Name
Address
Address (Continued)
City
State/Province
ZIP/Postal Code
Country
  • Privacy Policy
  • Terms of Use
  • Home
  • About
  • Subscribe
  • Advertise
  • Contact Us

©2019 Green Hill Healthcare Communications, LLC, an affiliate of The Lynx Group. All rights reserved.
1249 South River Road - Suite 202, Cranbury, NJ 08512

  • Home
  • Issues
    • 2018
      • November 2018 - Vol 11 No 5
      • September 2018 - Vol 11 No 4
      • July 2018 - Vol 11 No 3
      • May 2018 - Vol 11 No 2
      • March 2018 - Vol 11 No 1
    • 2017
      • November 2017 - Vol 10 No 6
      • September 2017 - Vol 10 No 5
      • July 2017 - Vol 10 No 4
      • May 2017 - Vol 10 No 3
      • March Vol 10 No 2
      • January Vol 10 No 1
    • 2016
      • November Vol 9 No 6
      • September Vol 9 No 5
      • July Vol 9 No 4
      • May Vol 9 No 3
      • March Vol 9 No 2
      • January Vol 9 No 1
    • Issue Archive
    • Special Issues
      • 2018 Guide to New FDA Approvals
  • Supplements
  • Categories
  • Conference Correspondent
    • ESMO 2018
      • ESMO 2018 Wrap-Up
    • HNF 2018
    • ASH 2017 - ITP
    • SABCS 2017 - Breast Cancer
    • ONS 2017 - Immunotherapy
    • ASH 2016 - Roundup
    • ASH 2016 - Multiple Myeloma
    • ASH 2015 - Multiple Myeloma
  • Web Exclusives
    • Drug Updates
    • FDA Approvals, News & Updates
    • In the News
    • Online First
    • Press Releases
    • Media Library
      • Video Library
        • TON Interview with the Innovators Series
      • Audiocast Library
  • Quick Quiz
  • CE
  • About
    • Contact Us
    • Editorial Board
    • Advertise
    • Resources
    • For Authors
      • Author Guidelines